Group 2 innate lymphoid cells (ILCs) that have previously been detected in the gut, lungs and adipose tissue express CD25 and interleukin-33 receptor (IL-33R) and produce IL-5 and IL-13 following stimulation. Here, Kim et al. characterize group 2 ILCs in the skin. LINCD25+IL-33R+ group 2 ILCs were detected in healthy human skin, and their numbers were increased in skin lesions from patients with atopic dermatitis. Moreover, group 2 ILCs producing IL-5 and IL-13 were enriched in the skin of mice with atopic dermatitis-like disease and promoted disease pathogenesis in these mice. Unlike group 2 ILCs at other anatomic locations, cutaneous group 2 ILCs did not require IL-25 and IL-33 signalling for their pathogenic function but instead depended on thymic stromal lymphopoietin, the levels of which are known to be increased in patients with atopic dermatitis.